TY - JOUR
T1 - Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
AU - Chalastanis, Alexandra
AU - Penard-Lacronique, Virginie
AU - Svrcek, Magali
AU - Defaweux, Valérie
AU - Antoine, Nadine
AU - Buhard, Olivier
AU - Dumont, Sylvie
AU - Fabiani, Bettina
AU - Renault, Isabelle
AU - Tubacher, Emmanuel
AU - Fléjou, Jean Franois
AU - Te Riele, Hein
AU - Duval, Alex
AU - Muleris, Martine
N1 - Funding Information:
This work was partly supported by grants to Alex Duval from the Association pour la Recherche contre le Cancer (ARC 1041) and to Martine Muleris from the GEFLUC (Groupement des Entreprises Françaises dans la LUtte contre le Cancer). Alexandra Chalastanis is a recipient of an MESR fellowship (Ministère de l’Enseignement Supérieur et de la Recherche).
PY - 2010/11/1
Y1 - 2010/11/1
N2 - Background The thiopurine prodrug azathioprine is used extensively in cancer therapy. Exposure to this drug results in the selection of DNA mismatch repair-deficient cell clones in vitro. It has also been suggested that thiopurine drugs might constitute a risk factor for the emergence of human neoplasms displaying microsatellite instability (MSI) because of deficient DNA mismatch repair. Methods Azathioprine was administered via drinking water (6-20 mg/kg body weight per day) to mice that were null (Msh2-/-; n = 27), heterozygous (Msh2+/-; n = 22), or wild type (Msh2 WT; n = 18) for the DNA mismatch repair gene Msh2. Control mice (45 Msh2-/-, 38 Msh2+/-, and 12 Msh2WT) received drinking water lacking azathioprine. The effect of azathioprine on tumorigenesis and survival of the mice was evaluated by Kaplan-Meier curves using log-rank and Gehan-Breslow-Wilcoxon tests. Mouse tumor samples were characterized by histology and immunophenotyping, and their MSI status was determined by polymerase chain reaction analysis of three noncoding microsatellite markers and by immunohistochemistry. Msh2 status of tumor samples was assessed by loss of heterozygosity analyses and sequencing after reverse transcription-polymerase chain reaction of the entire Msh2 coding sequence. All statistical tests were two-sided. Results Most untreated Msh2WT and Msh2+/- mice remained asymptomatic and alive at 250 days of age, whereas azathioprine-treated Msh2WT and Msh2+/- mice developed lymphomas and died prematurely (median survival of 71 and 165 days of age, respectively). Azathioprine-treated Msh2+/- mice developed diffuse lymphomas lacking Msh2 expression and displaying MSI due to somatic inactivation of the functional Msh2 allele by loss of heterozygosity or mutation. By contrast, azathioprine-treated Msh2WT mice displayed no obvious tumor phenotype, but histological examination showed microscopic splenic foci of neoplastic lymphoid cells that retained Msh2 expression and did not display MSI. Both untreated and azathioprine-treated Msh2-/- mice had a reduced lifespan compared with untreated Msh2WT mice (median survival of 127 and 107 days of age, respectively) and developed lymphomas with MSI. Conclusion Azathioprine-induced carcinogenesis in mice depends on the number of functional copies of the Msh2 gene. The Author 2010. Published by Oxford University Press.2010
AB - Background The thiopurine prodrug azathioprine is used extensively in cancer therapy. Exposure to this drug results in the selection of DNA mismatch repair-deficient cell clones in vitro. It has also been suggested that thiopurine drugs might constitute a risk factor for the emergence of human neoplasms displaying microsatellite instability (MSI) because of deficient DNA mismatch repair. Methods Azathioprine was administered via drinking water (6-20 mg/kg body weight per day) to mice that were null (Msh2-/-; n = 27), heterozygous (Msh2+/-; n = 22), or wild type (Msh2 WT; n = 18) for the DNA mismatch repair gene Msh2. Control mice (45 Msh2-/-, 38 Msh2+/-, and 12 Msh2WT) received drinking water lacking azathioprine. The effect of azathioprine on tumorigenesis and survival of the mice was evaluated by Kaplan-Meier curves using log-rank and Gehan-Breslow-Wilcoxon tests. Mouse tumor samples were characterized by histology and immunophenotyping, and their MSI status was determined by polymerase chain reaction analysis of three noncoding microsatellite markers and by immunohistochemistry. Msh2 status of tumor samples was assessed by loss of heterozygosity analyses and sequencing after reverse transcription-polymerase chain reaction of the entire Msh2 coding sequence. All statistical tests were two-sided. Results Most untreated Msh2WT and Msh2+/- mice remained asymptomatic and alive at 250 days of age, whereas azathioprine-treated Msh2WT and Msh2+/- mice developed lymphomas and died prematurely (median survival of 71 and 165 days of age, respectively). Azathioprine-treated Msh2+/- mice developed diffuse lymphomas lacking Msh2 expression and displaying MSI due to somatic inactivation of the functional Msh2 allele by loss of heterozygosity or mutation. By contrast, azathioprine-treated Msh2WT mice displayed no obvious tumor phenotype, but histological examination showed microscopic splenic foci of neoplastic lymphoid cells that retained Msh2 expression and did not display MSI. Both untreated and azathioprine-treated Msh2-/- mice had a reduced lifespan compared with untreated Msh2WT mice (median survival of 127 and 107 days of age, respectively) and developed lymphomas with MSI. Conclusion Azathioprine-induced carcinogenesis in mice depends on the number of functional copies of the Msh2 gene. The Author 2010. Published by Oxford University Press.2010
UR - http://www.scopus.com/inward/record.url?scp=78649355858&partnerID=8YFLogxK
U2 - 10.1093/jnci/djq389
DO - 10.1093/jnci/djq389
M3 - Article
C2 - 20923998
AN - SCOPUS:78649355858
SN - 0027-8874
VL - 102
SP - 1731
EP - 1740
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 22
ER -